94 related articles for article (PubMed ID: 15264876)
1. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Forte LR; Volkert WA
Bioconjug Chem; 2004; 15(4):872-80. PubMed ID: 15264876
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Volkert WA; Forte LR
Breast Cancer Res Treat; 2006 Jul; 98(1):7-15. PubMed ID: 16724166
[TBL] [Abstract][Full Text] [Related]
3. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
Roosenburg S; Laverman P; Joosten L; Eek A; Oyen WJ; de Jong M; Rutjes FP; van Delft FL; Boerman OC
Bioconjug Chem; 2010 Apr; 21(4):663-70. PubMed ID: 20302291
[TBL] [Abstract][Full Text] [Related]
4. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
Giblin MF; Sieckman GL; Watkinson LD; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA
Anticancer Res; 2006; 26(5A):3243-51. PubMed ID: 17094436
[TBL] [Abstract][Full Text] [Related]
5. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers.
Gali H; Sieckman GL; Hoffman TJ; Owen NK; Mazuru DG; Forte LR; Volkert WA
Bioconjug Chem; 2002; 13(2):224-31. PubMed ID: 11906259
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.
Liu D; Overbey D; Watkinson LD; Smith CJ; Daibes-Figueroa S; Hoffman TJ; Forte LR; Volkert WA; Giblin MF
Bioconjug Chem; 2010 Jul; 21(7):1171-6. PubMed ID: 20536242
[TBL] [Abstract][Full Text] [Related]
8. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
9. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
11. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
Harris TD; Kalogeropoulos S; Nguyen T; Dwyer G; Edwards DS; Liu S; Bartis J; Ellars C; Onthank D; Yalamanchili P; Heminway S; Robinson S; Lazewatsky J; Barrett J
Bioconjug Chem; 2006; 17(5):1294-313. PubMed ID: 16984141
[TBL] [Abstract][Full Text] [Related]
14. Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
Dijkgraaf I; Liu S; Kruijtzer JA; Soede AC; Oyen WJ; Liskamp RM; Corstens FH; Boerman OC
Nucl Med Biol; 2007 Jan; 34(1):29-35. PubMed ID: 17210459
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
16. Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core.
García Garayoa E; Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwe DA; Schibli R; Schubiger PA
Bioconjug Chem; 2008 Dec; 19(12):2409-16. PubMed ID: 18998719
[TBL] [Abstract][Full Text] [Related]
17. [111In-DOTA]LTT-SS28, a first pansomatostatin radioligand for in vivo targeting of somatostatin receptor-positive tumors.
Maina T; Cescato R; Waser B; Tatsi A; Kaloudi A; Krenning EP; de Jong M; Nock BA; Reubi JC
J Med Chem; 2014 Aug; 57(15):6564-71. PubMed ID: 25007399
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties.
Parry JJ; Kelly TS; Andrews R; Rogers BE
Bioconjug Chem; 2007; 18(4):1110-7. PubMed ID: 17503761
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
Eberle AN; Froidevaux S
J Mol Recognit; 2003; 16(5):248-54. PubMed ID: 14523936
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
